HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AB&B BIO-TECH-B

29.320

0.000

Volume:- -

Turnover:- -

Market Cap:11.52B

PE:-34.96

High:29.320

Open:29.320

Low:29.320

Close:29.320

52wk High:73.000

52wk Low:28.880

Shares:393.00M

HK Float Shares:296.36M

Volume Ratio:0.51

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:--

ROA:--

PB:293.39

PE(LYR):-34.96

PS:30.50

Loading ...

Overview Company News Filings

Ab&B Bio-Tech Calls 27 May 2026 EGM; Plans to Abolish Supervisory Committee, Revamp Governance and Appoint New INED & Auditor

Bulletin Express

AB&B Bio-Tech announces 2026 extraordinary general meeting

AB&B BIO-TECH-B Receives Stock Exchange Resumption Guidance, Trading Halt Continues

AB&B Bio-Tech auditor resignation delays annual results, shares remain suspended in Hong Kong

AB&B BIO-TECH-B Appoints Pak Shun as New Auditor

Ab&B Bio-Tech Nominates Ms. Lui Mei Ka as Independent Director, Plans Audit Committee Adjustment and Charter Revision

Bulletin Express

AB&B BIO-TECH-B Nominates Leimeijia as Independent Non-Executive Director Candidate

AB&B BIO-TECH-B Appoints Pak Chun as New Auditor

AB&B Bio-Tech nominates Lui Mei Ka as independent non-executive director candidate

AB&B Bio-Tech Proposes Prism Hong Kong as Successor Auditor; 2025 Audit Targeted for Completion by May 2026

Bulletin Express

AB&B Bio-Tech names Prism Hong Kong as new auditor after Deloitte resignation

AB&B BIO-TECH-B Announces Changes to Strategy Committee Composition

AB&B Bio-Tech files list of directors with Hong Kong Stock Exchange

AB&B Bio-Tech proposes bylaw amendments to align with PRC Company Law updates

Nationwide Bidding Progresses Steadily: First and Only Pan-Population Trivalent Influenza Subunit Vaccine Supports Global 2026 Flu Prevention

AB&B Bio-Tech faces Deloitte resignation over HK$272.00 million fund dealings; trading suspension continues

Bulletin Express

AB&B BIO-TECH-B Announces Resignation of Auditor Deloitte

AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments

AB&B Bio-Tech Reports Stable Share Capital and Full Public Float Compliance in March 2026 Update

Bulletin Express

AB&B BIO-TECH-B (02627) to Suspend Trading from April 1st Pending Release of 2025 Annual Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/02627/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"AB&B BIO-TECH-B","latestPrice":29.32,"timestamp":1787275207144,"preClose":29.32,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":296361845,"shares":393000000,"eps":-0.8385895589238526,"marketStatus":"Halted","change":0,"latestTime":"08-21 09:20:07","open":29.32,"high":29.32,"low":29.32,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.7293047071646448,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":29.32,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.5100838100119135,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.83859,"volumeRatio":0.5100838100119135,"shares":393000000,"dividePrice":0,"high":29.32,"amplitude":0,"preClose":29.32,"low":29.32,"week52Low":28.88,"pbRate":"293.39","psRate":"30.50","week52High":73,"institutionHeld":0,"latestPrice":29.32,"eps":-0.8385895589238526,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.7293047071646448,"open":29.32,"prevYearClose":40.24,"prevWeekClose":29.32,"prevMonthClose":29.32,"prevQuarterClose":29.32,"fiveDayClose":29.32,"twentyDayClose":29.32,"sixtyDayClose":29.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null},{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2026-08-21","current":-40.202675,"percent":0.988142,"low":-109.844469,"twenty":-74.600848,"median":-63.899985,"eighty":-44.518459,"high":-18.07815,"avg":-59.988502,"sd":14.538107,"marketCap":11535737032},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-14","current":-69.152784,"twenty":-76.901535,"median":-66.692171,"eighty":-63.572329,"marketCap":16996720320},{"date":"2025-11-21","current":-64.47659,"twenty":-76.671062,"median":-66.251138,"eighty":-63.813259,"marketCap":15839999076},{"date":"2025-11-28","current":-66.221916,"twenty":-76.081201,"median":-65.883561,"eighty":-63.948664,"marketCap":16327867900},{"date":"2025-12-05","current":-64.387851,"twenty":-75.140133,"median":-65.711289,"eighty":-64.052768,"marketCap":15902949892},{"date":"2025-12-12","current":-65.09579,"twenty":-74.230454,"median":-65.51992,"eighty":-64.060512,"marketCap":16107540044},{"date":"2025-12-19","current":-64.75238,"twenty":-73.314016,"median":-65.09579,"eighty":-64.128623,"marketCap":16060326932},{"date":"2025-12-24","current":-63.88714,"twenty":-72.937878,"median":-65.019631,"eighty":-64.128296,"marketCap":15895081040},{"date":"2026-01-02","current":-63.38466,"twenty":-72.68164,"median":-64.955716,"eighty":-63.907691,"marketCap":15832130224},{"date":"2026-01-09","current":-64.42138,"twenty":-72.421694,"median":-64.920623,"eighty":-63.984499,"marketCap":16131146600},{"date":"2026-01-16","current":-79.012958,"twenty":-72.68164,"median":-65.002626,"eighty":-63.984499,"marketCap":19849179170},{"date":"2026-01-23","current":-80.264585,"twenty":-74.684429,"median":-65.09579,"eighty":-64.012742,"marketCap":20144261120},{"date":"2026-01-30","current":-75.685884,"twenty":-76.499114,"median":-65.441715,"eighty":-64.034272,"marketCap":19081966100},{"date":"2026-02-06","current":-72.661412,"twenty":-75.84841,"median":-65.678772,"eighty":-64.110439,"marketCap":18365900568},{"date":"2026-02-13","current":-79.706332,"twenty":-76.558032,"median":-65.817553,"eighty":-64.12895,"marketCap":20262293900},{"date":"2026-02-20","current":-82.611175,"twenty":-76.790716,"median":-65.857422,"eighty":-64.132361,"marketCap":20970490580},{"date":"2026-02-27","current":-82.941496,"twenty":-77.55936,"median":-66.221916,"eighty":-64.146544,"marketCap":21285244660},{"date":"2026-03-06","current":-81.374491,"twenty":-78.249638,"median":-66.33369,"eighty":-64.163416,"marketCap":20714752890},{"date":"2026-03-13","current":-88.155391,"twenty":-78.824484,"median":-66.830053,"eighty":-64.221195,"marketCap":22544260980},{"date":"2026-03-20","current":-60.352659,"twenty":-78.705126,"median":-66.485266,"eighty":-64.132361,"marketCap":15375736808},{"date":"2026-03-27","current":-47.779776,"twenty":-78.691316,"median":-66.244034,"eighty":-64.004997,"marketCap":12141638636},{"date":"2026-04-02","current":-45.178314,"twenty":-78.677046,"median":-65.897052,"eighty":-63.746879,"marketCap":11535737032},{"date":"2026-04-10","current":-44.832534,"twenty":-78.441179,"median":-65.857422,"eighty":-63.430885,"marketCap":11535737032},{"date":"2026-04-17","current":-44.813717,"twenty":-78.181043,"median":-65.711289,"eighty":-63.227242,"marketCap":11535737032},{"date":"2026-04-24","current":-44.811176,"twenty":-78.060991,"median":-65.51992,"eighty":-62.332762,"marketCap":11535737032},{"date":"2026-04-30","current":-44.783221,"twenty":-78.021843,"median":-65.28076,"eighty":-60.389723,"marketCap":11535737032},{"date":"2026-05-08","current":-44.644729,"twenty":-77.873074,"median":-65.02482,"eighty":-59.352088,"marketCap":11535737032},{"date":"2026-05-15","current":-44.527613,"twenty":-77.457906,"median":-64.955716,"eighty":-54.162029,"marketCap":11535737032},{"date":"2026-05-22","current":-44.62961,"twenty":-77.130506,"median":-64.865742,"eighty":-48.015114,"marketCap":11535737032},{"date":"2026-05-29","current":-44.474957,"twenty":-77.072723,"median":-64.7737,"eighty":-45.186782,"marketCap":11535737032},{"date":"2026-06-05","current":-44.410504,"twenty":-76.942339,"median":-64.709555,"eighty":-44.836445,"marketCap":11535737032},{"date":"2026-06-12","current":-44.440563,"twenty":-76.790716,"median":-64.652972,"eighty":-44.816847,"marketCap":11535737032},{"date":"2026-06-18","current":-44.334195,"twenty":-76.784092,"median":-64.606806,"eighty":-44.811176,"marketCap":11535737032},{"date":"2026-06-26","current":-44.551763,"twenty":-76.501517,"median":-64.559082,"eighty":-44.783221,"marketCap":11535737032},{"date":"2026-07-03","current":-44.518459,"twenty":-76.499114,"median":-64.484566,"eighty":-44.746029,"marketCap":11535737032},{"date":"2026-07-10","current":-44.573161,"twenty":-76.047687,"median":-64.42138,"eighty":-44.683785,"marketCap":11535737032},{"date":"2026-07-17","current":-44.415099,"twenty":-75.735703,"median":-64.384175,"eighty":-44.631174,"marketCap":11535737032},{"date":"2026-07-24","current":-44.405121,"twenty":-75.569622,"median":-64.258799,"eighty":-44.611538,"marketCap":11535737032},{"date":"2026-07-31","current":-44.320924,"twenty":-75.486659,"median":-64.151322,"eighty":-44.575108,"marketCap":11535737032},{"date":"2026-08-07","current":-44.235034,"twenty":-75.015399,"median":-64.128705,"eighty":-44.551763,"marketCap":11535737032},{"date":"2026-08-14","current":-44.179104,"twenty":-74.694617,"median":-64.015323,"eighty":-44.527613,"marketCap":11535737032},{"date":"2026-08-21","current":-44.081684,"twenty":-74.600848,"median":-63.899985,"eighty":-44.518459,"marketCap":11535737032}],"updateTime":1787452383350},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141249357","title":"Ab&B Bio-Tech Calls 27 May 2026 EGM; Plans to Abolish Supervisory Committee, Revamp Governance and Appoint New INED & Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1141249357","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141249357?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:22","pubTimestamp":1778192560,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS has issued a circular convening an Extraordinary General Meeting (EGM) for 10:00 a.m. (Hong Kong time) on 27 May 2026 at No. 32 Xinglin Road, Medical High-tech Zone,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126730","title":"AB&B Bio-Tech announces 2026 extraordinary general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126730","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633126730?lang=en_us&edition=fundamental","pubTime":"2026-05-07 22:56","pubTimestamp":1778165774,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech will hold an extraordinary general meeting in Taizhou, Jiangsu, on May 27, 2026.Shareholders will vote on scrapping supervisory committee, followed by amendments to articles of association.Meeting will also consider changes to internal corporate governance policies, appointment of an independent non-executive director, appointment of Prism as auditor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 07, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLb6Dv3b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142399380","title":"AB&B BIO-TECH-B Receives Stock Exchange Resumption Guidance, Trading Halt Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1142399380","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142399380?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:17","pubTimestamp":1777457853,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) announced that on April 24, 2026, the company received a letter from the Stock Exchange outlining the following guidance for resuming trading of its shares: (i) Conduct an...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631996575","title":"AB&B Bio-Tech auditor resignation delays annual results, shares remain suspended in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2631996575","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631996575?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:00","pubTimestamp":1777456816,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech shares remain suspended in Hong Kong since April 1, 2026 due to delayed publication of fiscal 2025 annual results.Stock Exchange issued resumption conditions that include publishing all outstanding financial results required under Listing Rules.Company must address any audit modifications as part of resumption process.HKEX warned listing may be cancelled if trading does not resume by Sept. 30, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL4h8qN1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148727676","title":"AB&B BIO-TECH-B Appoints Pak Shun as New Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148727676","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148727676?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:30","pubTimestamp":1777249845,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced that, following the resignation of Deloitte Touche Tohmatsu and the resulting vacancy in the company's auditor position, the Board of Directors has resolved,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105109040","title":"Ab&B Bio-Tech Nominates Ms. Lui Mei Ka as Independent Director, Plans Audit Committee Adjustment and Charter Revision","url":"https://stock-news.laohu8.com/highlight/detail?id=1105109040","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105109040?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:43","pubTimestamp":1777041806,"startTime":"0","endTime":"0","summary":"Ab&B Bio-Tech CO., LTD. JS has proposed three board-level changes aimed at strengthening governance and internal controls. The Board has nominated Ms. Lui Mei Ka, aged 38, to serve as an independent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169293447","title":"AB&B BIO-TECH-B Nominates Leimeijia as Independent Non-Executive Director Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1169293447","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169293447?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:38","pubTimestamp":1777041517,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced a proposal from its board of directors. The board has recommended the nomination of Ms. Leimeijia as a candidate for independent non-executive director for the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160023017","title":"AB&B BIO-TECH-B Appoints Pak Chun as New Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1160023017","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160023017?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:32","pubTimestamp":1777041134,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced that following the resignation of Deloitte Touche Tohmatsu, the position of the company's auditor became vacant. The board of directors has resolved, upon the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629984096","title":"AB&B Bio-Tech nominates Lui Mei Ka as independent non-executive director candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2629984096","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629984096?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:25","pubTimestamp":1777040706,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech nominated Lui Mei Ka as independent non-executive director, pending shareholder vote.Lui is managing director at Merit Corporate Services, previously served as CFO and company secretary at GR Life Style.Audit Committee lineup set to change, with Lui slated to join once elected.Articles of association amendments would shift board structure to at least three independent non-executive directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLb0MjG0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","00108","BK1229","BK1258","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116430595","title":"AB&B Bio-Tech Proposes Prism Hong Kong as Successor Auditor; 2025 Audit Targeted for Completion by May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1116430595","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116430595?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:23","pubTimestamp":1777040588,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech CO., LTD. JS announced a plan to appoint Prism Hong Kong Limited as its new external auditor, filling the vacancy created by the recent resignation of Deloitte Touche Tohmatsu. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629840837","title":"AB&B Bio-Tech names Prism Hong Kong as new auditor after Deloitte resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840837","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629840837?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:17","pubTimestamp":1777040249,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech proposed appointing Prism Hong Kong as auditor to fill vacancy left by Deloitte Touche Tohmatsu resignation.Appointment takes effect once shareholders approve it at a general meeting.Prism forecast completion of fiscal 2025 audit by end-May 2026.Proposed audit fee set at RMB 2.4 million.H-share trading remains suspended since April 1, 2026 amid delayed 2025 annual results.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDL5lb7Xh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190169040","title":"AB&B BIO-TECH-B Announces Changes to Strategy Committee Composition","url":"https://stock-news.laohu8.com/highlight/detail?id=1190169040","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190169040?lang=en_us&edition=fundamental","pubTime":"2026-04-19 19:40","pubTimestamp":1776598814,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced that its board of directors has reviewed and approved an adjustment to the membership of the board's strategy committee. The changes are effective from the date...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628764655","title":"AB&B Bio-Tech files list of directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2628764655","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628764655?lang=en_us&edition=fundamental","pubTime":"2026-04-19 19:36","pubTimestamp":1776598616,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech  filed updated list of directors with Hong Kong Stock Exchange dated April 19, 2026.An Youcai listed as executive director, serving as chairman of board.Board comprised three executive directors, three non-executive directors, three independent non-executive directors.Committee leadership set out for four board committees, including Audit Committee chaired by Li Jianjun.Remuneration and Appraisal Committee chaired by Chen Chengbei, Nomination Committee chaired by Li Xiangming.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 19, 2026, and is so","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260419:nNDL3WrttZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628645267","title":"AB&B Bio-Tech proposes bylaw amendments to align with PRC Company Law updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2628645267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628645267?lang=en_us&edition=fundamental","pubTime":"2026-04-19 19:32","pubTimestamp":1776598365,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech proposed amendments to articles of association to align with latest PRC Company Law requirements.Changes would remove supervisory committee framework, shifting its statutory duties to audit committee.Amendments also include updates to reflect company needs, with textual cleanups.Revisions require shareholder approval at general meeting via special resolution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260419:nNDL1dNdSc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126883295","title":"Nationwide Bidding Progresses Steadily: First and Only Pan-Population Trivalent Influenza Subunit Vaccine Supports Global 2026 Flu Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=1126883295","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126883295?lang=en_us&edition=fundamental","pubTime":"2026-04-14 16:34","pubTimestamp":1776155680,"startTime":"0","endTime":"0","summary":"Recent market developments indicate that Jiangsu AB&B BIO-TECH Biotechnology Co., Ltd., known as AB&B BIO-TECH-B (02627), has achieved further success with its independently developed trivalent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164228869","title":"AB&B Bio-Tech faces Deloitte resignation over HK$272.00 million fund dealings; trading suspension continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1164228869","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164228869?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:23","pubTimestamp":1776126237,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech CO., LTD. JS announced that Deloitte Touche Tohmatsu has resigned as auditor with immediate effect on 14 April 2026, prompting a formal process to appoint a replacement subject to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159271696","title":"AB&B BIO-TECH-B Announces Resignation of Auditor Deloitte","url":"https://stock-news.laohu8.com/highlight/detail?id=1159271696","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159271696?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:18","pubTimestamp":1776125901,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced that its auditor, Deloitte Touche Tohmatsu (Deloitte), resigned from its position with immediate effect on April 13, 2026.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627462859","title":"AB&B Bio-Tech auditor Deloitte resigns, citing concerns over HK$272 million fund investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2627462859","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627462859?lang=en_us&edition=fundamental","pubTime":"2026-04-14 08:12","pubTimestamp":1776125532,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech auditor Deloitte Touche Tohmatsu resigned with immediate effect on April 13, 2026 during audit of fiscal 2025 results.Deloitte flagged HKD 272 million of fund subscriptions made shortly after August 2025 IPO, followed by redemptions on Dec. 30, 2025 with low return.Deloitte also raised concerns over consultancy payments of about HKD 36 million before year-end, plus about HKD 22 million after year-end, involving consultants linked to entities tied to fund investments.Auditor urged an independent forensic investigation, citing concerns over commercial substance of transactions.Shares remain suspended from April 1, 2026 while company seeks shareholder approval to appoint a new auditor to complete fiscal 2025 audit.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL4QY3gv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107515918","title":"AB&B Bio-Tech Reports Stable Share Capital and Full Public Float Compliance in March 2026 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1107515918","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107515918?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:42","pubTimestamp":1775731354,"startTime":"0","endTime":"0","summary":"AB&B Bio-Tech (02627) disclosed its Monthly Return for the period ended 31 March 2026, confirming that no changes occurred in either its authorised or issued share capital during the month....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165582538","title":"AB&B BIO-TECH-B (02627) to Suspend Trading from April 1st Pending Release of 2025 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1165582538","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165582538?lang=en_us&edition=fundamental","pubTime":"2026-04-01 08:44","pubTimestamp":1775004251,"startTime":"0","endTime":"0","summary":"AB&B BIO-TECH-B (02627) has announced a suspension of trading for its shares. The halt will commence at 9:00 a.m. on Wednesday, April 1, 2026, on the Stock Exchange of Hong Kong. Trading will remain suspended until the company publishes its financial results for the full year ending 2025.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}